Home › Leiomyosarcoma › NCT06875700
Beliefs, Attitudes, and Response to Genetic Testing in SarcomaPatients
Beliefs, Attitudes, and Response to Genetic Testing in Sarcoma Patients
Who can join
Ages 18 and older · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion LMS Proband * Actionable germline PV detected in the research context * Living * No prior germline testing for this PV * Able to speak and read English * Mentally competent * Age 18 or older Relative of LMS Proband * 25-50% chance for having inherited the PV * No prior germline testing for this PV * Able to speak and read English * Mentally competent * Age 18 or older Exclusion (both cohorts) * \<18 years * Unable to read or write
About the study
Genomic research has shown that a portion of leiomyosarcomas can be attributed to an underlying cancer predisposition syndrome. However, the optimal approach for incorporating germline testing into the care of these patients. This study is assessing the beliefs about the heritability of leiomyosarcoma and other cancer risks, and attitudes towards germline testing among leiomyosarcoma patients.
Sponsor: University of Utah · Participants: 300 · Started: Jul 9, 2024
Contact the study team
- Gregg Wood · Phone: 8016464215
Official record on ClinicalTrials.gov — NCT06875700
Locations in the U.S.
| Utah | Huntsman Cancer Institute at the University of Utah, Salt Lake City |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.